Ameliorative effects of metformin on renal histologic and biochemical alterations of gentamicin-induced renal toxicity in Wistar rats Sir, Recently, we published an article in J Res Med Sci, entitled "Ameliorative effects of metformin on renal histologic and biochemical alterations of gentamicin-induced renal toxicity in Wistar rats." [1] In this article, it is concluded that metformin (MF) may prevent or ameliorate GM-induced acute renal failure, and therefore, it might be beneficial in patients under treatment with this medicine. [1] In this letter, we would like to point out a few points about the mentioned conclusion. In an agreement with our findings, Taheri et al. recently conducted a study on the effects of MF on renal function and structure after unilateral ischemia-reperfusion in rat. They found that MF provided some renal protection against ischemia and reperfusion (I/R) induced injury to the rats kidney. They concluded that MF with activation of adenosine monophosphate-activated protein kinase (AMPK) and endothelial nitric oxide synthase have tissue protective effects. [2] More recently, Kim et al. performed a study using MF (350 mg/kg/day) for spontaneously diabetic Torii (SDT) rats for 17 weeks. They examined blood glucose, glycated hemoglobin and albuminuria, kidney histopathology, renal 8-hydroxydeoxyguanosine levels, and also apoptosis. They found that treatment of SDT rats with MF restored podocyte loss. They suggested that diabetes-induced podocyte loss in diabetic nephropathy could be suppressed by MF, through the repression of oxidative injury. [3] letter tO editOr
